Skip to main content

Table 1 Baseline characteristics of CRC-FOLFOX plasma proteome profiling cohort

From: Plasma proteomic characterization of colorectal cancer patients with FOLFOX chemotherapy by integrated proteomics technology

Characteristics

Total

SENS

NONE

P-value

Number of samples (n)

90

60

30

–

Age (years, mean ± SD)

57 ± 22

56 ± 20

56 ± 21

0.14

Gender (male, %)

57(63%)

38(63%)

19(63%)

–

BMI (kg/m2, mean ± SD)

23.34 ± 2.48

23.34 ± 2.5

23.62 ± 1.5

0.300

CA125 (U/mL)

13.54 (10.01–17.92)

13.10 (10.08–17.84)

13.72 (9.77–21.36)

0.494

CEA (ng/mL)

3.11 (2.14–5.09)

2.61 (1.88–3.93)

3.74 (2.80–16.45)

0.499

CA19-9 (U/mL)

11.19 (7.76–17.81)

10.62 (7.68–13.74)

12.83 (7.62–26.15)

0.500